NCSS is expanding the range of laboratory services: more than 300 studies were performed between 2024 and 2026

The National Center for Standard Samples continues to actively develop the field of laboratory research for the pharmaceutical industry. In the period from 2024 to 2026, the company's specialists performed more than 300 laboratory studies, which became a significant stage in expanding the research and analytical capabilities of the center.

The key growth factor was the completion of the construction of a new laboratory complex in December 2023. The commissioning of the modern complex has significantly expanded the company's capabilities in the field of development, certification and production of standard samples of active pharmaceutical substances and their impurity compounds.

The new laboratory complex is equipped with advanced analytical equipment from the world's leading manufacturers, which allows performing a wide range of studies with high accuracy and reproducibility of results. Today, the NCSS provides quality control services for medicines, conducts research and development (R&D), and implements projects aimed at developing the national system of reference materials.

The increase in the number of completed studies confirms the high level of trust on the part of pharmaceutical companies and scientific organizations. Over the past 2 years, the number of organizations applying for the company's laboratory services has increased more than 10 times. This indicates the growing confidence on the part of pharmaceutical companies and the scientific community in the quality of research and the professional expertise of NCSS specialists.

The development of laboratory facilities remains one of the strategic activities of the NCSS. The Company continues to expand the list of research performed and improve analytical approaches in accordance with the current needs of the pharmaceutical industry.